Chlamydia are bacteria that cause sexually transmitted infections. Around 130 million people worldwide are infected with chlamydia. The biggest problem is that the infection usually causes no noticeable symptoms. It therefore often goes unnoticed – which facilitates the spread of the pathogen and leads to severe or chronic conditions such as cervical and ovarian cancer.
Until now, it was not known what the crucial step is that triggers the bacteria to multiply. A research team at Julius Maximilian University of Würzburg (JMU) has now discovered it. This is important because the very first step in the pathogen’s replication is likely to be a good target for drugs.
In the case of chlamydia, the first step involves reprogramming the metabolism of their human host cells. The cells then increase their uptake of the amino acid glutamine from their surroundings. They require this amino acid to synthesise the ring-shaped molecule peptidoglycan, which is needed to build cell walls. If this process fails – for example, because the glutamine import system is not functioning – the bacterial pathogens can no longer multiply.
References:
Julius Maximilian University of Würzburg (JMU)
press release
Reprogramming of host glutamine metabolism during Chlamydia trachomatis infection and its key role in peptidoglycan synthesis; *Nature Microbiology*, 3 August 2020,
DOI: https://doi.org/10.1038/s41564-020-0762-5